Speakers

Expand/Collapse

John Murphy
Chief Scientific Officer
Arbor Biotechnologies

Day One

Wednesday November 17, 2021

4:30 pm | Arbor Discovery’s Novel Process and Protein Engineering Approach

Roy Ziblat
Scientific Manager
Arbor Biotechnologies

Day Two

Thursday November 18, 2021

12:45 pm | Function & Discoveries of the Arbor Discovery Line Using Type V Systems

Marco Weinberg
Vice President, Research & Development
AskBio

Day One

Wednesday November 17, 2021

12:00 pm | CRISPR Delivery via the Use of Adeno Associated Viral Vectors

9:45 am | Panel Discussion: Driving CRISPR Technology to the Clinic

Luisa Loiacono
Senior Research Scientist
AstraZeneca

Day One

Wednesday November 17, 2021

9:45 am | Panel Discussion: Driving CRISPR Technology to the Clinic

Day Two

Thursday November 18, 2021

9:15 am | Evaluating the Main Safety Considerations of Base Editing

Joseph Miano
J. Harold Harrison, MD, Distinguished University Chair in Vascular Biology
Augusta University

Jacob Layer
Senior Scientist, Group Leader
eGenesisbio

Day Two

Thursday November 18, 2021

12:15 pm | Innovating Xenotransplantation with Genome Editing

Pankaj Mandal
Senior Staff Fellow, Office of Tissues & Advanced Therapies, Division of Cellular & Gene Therapies
FDA/CBER

Day One

Wednesday November 17, 2021

9:15 am | FDA’s Regulatory Approach to CRISPR Technology

Kalina Paunovska
Postdoctoral Scholars
Georgia Institute of Technology, Dahlman Lab

Day One

Wednesday November 17, 2021

2:00 pm | CRISPR Delivery via the Use of Lipid Nanoparticles Delivery

Danilo Maddalo
Senior Scientist
Genentech

Day One

Wednesday November 17, 2021

9:45 am | Panel Discussion: Driving CRISPR Technology to the Clinic

Day Two

Thursday November 18, 2021

3:45 pm | SEMMs: Somatically Engineered Mouse Models, A New Tool for Translational Preclinical Research

Danny Dever
Head of Discovery Research
GraphiteBio

Day One

Wednesday November 17, 2021

9:45 am | Panel Discussion: Driving CRISPR Technology to the Clinic

Day Two

Thursday November 18, 2021

3:15 pm | Investigate the Therapeutic Potential of CRISPR Technology in Treating Sickle Cell Disease

Ben Kleinstiver
Assistant Professor
Mass General Hospital & Harvard Medical School

Day One

Wednesday November 17, 2021

4:00 pm | Useful Engineered CRISPR-Cas Enzymes with Enhanced Properties

Sean Burns
Vice President, Disease Biology
Intellia Therapeutics

Day Two

Thursday November 18, 2021

2:45 pm | Development of Systemic CRISPR-based Therapeutics

Triparna Sen
Assistant Attending
Memorial Sloan Kettering Cancer Center

Day Two

Thursday November 18, 2021

2:15 pm | Preclinical Platform for CRISPR-Mediated Gene Editing

Gregory Cost
Senior Director of Biology
Metagenomi

Day One

Wednesday November 17, 2021

3:30 pm | Novel CRISPR-Associated Gene-Editing Systems Discovered in Metagenomic Samples Enable Efficient & Specific Genome Engineering For Cell Therapy Development

Brett Staahl
Vice President Platform, Co- Founder
Scribe Therapeutics

Day One

Wednesday November 17, 2021

11:30 am | Solving the Challenges of Editing & In Vivo Delivery

Niren Murthy
Professor, Bioengineering
University of California at Berkeley

Day One

Wednesday November 17, 2021

1:30 pm | New Delivery Vehicles for Gene Editing Enzymes

Andrew Anzalone
Head of Prime Editing Platforms
Prime Medicine

Day Two

Thursday November 18, 2021

10:15 am | Exploring the Potential of Prime Editing

Jyun-Liang “Aaron” Lin
Scientist II
Metagenomi

Day Two

Thursday November 18, 2021

9:45 am | Compact Adenine Base Editor with Novel Microbial Components

Rafi Emmanuel
Senior Vice President, R&D
Emendo Biotherapeutics

Clarence Mills
Research Scientist
Horizon Discovery